Sinco Pharmaceuticals Holdings Limited (HKG:6833)

HKG:6833 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	329	400	488	539	3,517	499
Market Cap Growth	-32.78%	-17.92%	-9.43%	-84.68%	604.67%	-19.18%
Enterprise Value	324	457	153	405	3,596	507
Last Close Price	0.16	0.19	0.23	0.25	1.78	0.28
PE Ratio	7.30	8.95	10.46	6.86	21.21	3.56
Forward PE	-	15.28	15.28	15.28	15.28	15.28
PS Ratio	0.12	0.13	0.17	0.21	1.42	0.21
PB Ratio	0.44	0.57	0.71	0.79	7.64	2.56
P/TBV Ratio	0.53	0.64	0.81	0.91	7.64	2.54
P/FCF Ratio	-	-	1.37	21.28	10.15	3.07
P/OCF Ratio	13.75	-	1.25	6.35	9.37	3.06
EV/Sales Ratio	0.12	0.15	0.06	0.16	1.45	0.21
EV/EBITDA Ratio	2.40	3.24	1.09	3.29	14.82	2.81
EV/EBIT Ratio	3.13	3.77	1.20	3.54	15.21	2.97
EV/FCF Ratio	-66.28	-	0.43	15.99	10.38	3.12
Debt / Equity Ratio	0.33	0.53	0.40	0.32	0.91	0.50
Debt / EBITDA Ratio	1.85	2.53	1.89	1.71	1.71	0.54
Debt / FCF Ratio	-	-	0.78	8.59	1.21	0.60
Asset Turnover	1.35	1.45	1.53	1.71	1.63	1.97
Inventory Turnover	14.03	10.95	22.44	25.81	10.87	6.97
Quick Ratio	0.85	0.74	0.84	0.91	0.76	0.74
Current Ratio	1.16	1.14	1.16	1.29	1.34	1.01
Return on Equity (ROE)	6.41%	6.51%	6.88%	14.19%	50.09%	112.13%
Return on Assets (ROA)	3.19%	3.66%	4.39%	4.76%	9.69%	8.62%
Return on Invested Capital (ROIC)	8.77%	8.45%	10.87%	16.53%	63.09%	215.42%
Return on Capital Employed (ROCE)	13.80%	17.00%	17.70%	16.00%	38.00%	55.00%
Earnings Yield	14.16%	11.17%	9.56%	14.58%	4.71%	28.11%
FCF Yield	-1.48%	-71.22%	73.19%	4.70%	9.85%	32.58%
Dividend Yield	1.23%	1.03%	1.67%	3.92%	-	-
Payout Ratio	8.62%	17.17%	42.77%	-	-	-
Buyback Yield / Dilution	0.04%	-	-0.07%	-16.93%	-2.69%	-
Total Shareholder Return	1.14%	1.03%	1.61%	-13.01%	-2.69%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.